Changes in the uninjected contralateral eye after intravitreal brolucizumab for exudative age-related macular degeneration. Mora P, Bellucci C, Radice LM, Manzotti F, et al. Eur J Ophthalmol 2023 Jul 9:11206721231187429. doi: 10.1177/11206721231187429.

Read + Share

Amedeo Smart

Independent Medical Education

Mora P, Bellucci C, Radice LM, Manzotti F, et al. Changes in the uninjected contralateral eye after intravitreal brolucizumab for exudative age-related macular degeneration. Eur J Ophthalmol 2023 Jul 9:11206721231187429. doi: 10.1177/11206721231187429.
PMID: 37424299